CTLA4Ig induces regulatory T cells that mediate linked regulation of allogeneic T cell responses.

被引：0
|
作者：
Lee, RS
Rusche, JR
Sachs, DH
Sayegh, MH
Madsen, JC
机构：
[1] Massachusetts Gen Hosp, Dept Surg, Div Cardiac Surg, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Surg, Transplantat Biol Res Ctr, Boston, MA 02114 USA
[3] Brigham & Womens Hosp, Lab Immunogenet & Transplantat, Boston, MA 02115 USA
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1101
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [21] Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis
    Bonelli, Michael
    Goeschl, Lisa
    Blueml, Stephan
    Karonitsch, Thomas
    Hirahara, Kiyoshi
    Ferner, Elisabeth
    Steiner, Carl-Walter
    Steiner, Guenter
    Smolen, Josef S.
    Scheinecker, Clemens
    RHEUMATOLOGY, 2016, 55 (04) : 710 - 720
  • [22] T follicular regulatory cells in the regulation of B cell responses
    Sage, Peter T.
    Sharpe, Arlene H.
    TRENDS IN IMMUNOLOGY, 2015, 36 (07) : 410 - 418
  • [23] Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients
    Lu, L
    Gambotto, A
    Lee, WC
    Qian, S
    Bonham, CA
    Robbins, PD
    Thomson, AW
    GENE THERAPY, 1999, 6 (04) : 554 - 563
  • [24] ABATACEPT (CTLA-4IG) THERAPY PREVENTS ACTIVATION INDUCED CELL DEATH (AICD) OF REGULATORY T CELLS AND REDUCES THE SUSCEPTIBILITY OF T CELLS TO REGULATORY T CELL SUPPRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
    Bonelli, M.
    Goeschl, L.
    S, Blueml
    Smolen, J. S.
    Scheinecker, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 : A10 - A10
  • [25] CTLA4Ig-induced regulatory NON-T cells in heart xenotransplantation.
    Seveno, C
    Haspot, F
    Coulon, F
    Merieu, E
    Usal, C
    Soulillou, JP
    Vanhove, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 368 - 369
  • [26] Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients
    L Lu
    A Gambotto
    W-C Lee
    S Qian
    C A Bonham
    P D Robbins
    A W Thomson
    Gene Therapy, 1999, 6 : 554 - 563
  • [27] Context-dependent regulation of T cell responses by CTLA-4
    Sansom, D.
    Qureshi, O.
    Baker, J.
    Briggs, Z.
    Hou, T.
    IMMUNOLOGY, 2011, 135 : 190 - 190
  • [28] Effect of CTLA-4-Ig on the Number and Function of T Regulatory Cells in Patients with Rheumatoid Arthritis
    Alvarez-Quiroga, C.
    Abud-Mendoza, C.
    Doniz-Padilla, L.
    Juarez-Reyes, A.
    Baranda, L.
    Gonzalez-Amaro, R.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1190 - 1190
  • [29] CTLA-4-IG (ABATACEPT) THERAPY REDUCES T CELL FUNCTION FOR ALL DEFINED CD4 CELL SUBSETS INCLUDING REGULATORY T CELLS (TREG)
    Herrath, Jessica
    Pieper, Jennifer
    van Vollenhoven, Ronald
    Malmstrom, Vivianne
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 : A4 - A4
  • [30] The role of CTLA-4 in the regulation and initiation of T-cell responses
    Chambers, CA
    Krummel, MF
    Boitel, B
    Hurwitz, A
    Sullivan, TJ
    Fournier, S
    Cassell, D
    Brunner, M
    Allison, JP
    IMMUNOLOGICAL REVIEWS, 1996, 153 : 27 - 46
12345